Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
OBJECTIVE: To examine the degree to which use of β blockers, statins, and diuretics in patients with impaired glucose tolerance and other cardiovascular risk factors is associated with new onset diabetes. DESIGN: Reanalysis of data from the Nateglinide and Valsartan in Impaired Glucose Tolerance Out...
Hauptverfasser: | Shen, L, Shah, B, Reyes, E, Thomas, L, Wojdyla, D, Diem, P, Leiter, L, Charbonnel, B, Mareev, V, Horton, E, Haffner, S, Soska, V, Holman, R, Bethel, M, Schaper, F, Sun, J, McMurray, J, Califf, R, Krum, H |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
2013
|
Ähnliche Einträge
Ähnliche Einträge
-
Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
von: Shen, L, et al.
Veröffentlicht: (2012) -
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
von: Mcmurray, J, et al.
Veröffentlicht: (2012) -
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.
von: McMurray, J, et al.
Veröffentlicht: (2012) -
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
von: Krum, H, et al.
Veröffentlicht: (2010) -
Association of non-alcoholic steatothepatitis with components of the metabolic syndrome in 43,509 patients screened for NAVIGATOR
von: Bethel, A, et al.
Veröffentlicht: (2005)